Biocon And Mylan Prime Pegfilgrastim Expansion

US FDA Approves Biocon’s sBLA for New Pegfilgrastim Facility

 
• By Anju Ghangurde
  
Warehouse_Worker
Biocon And Mylan Build Additional Capacity For Fulphila • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Regulation

More from Policy & Regulation